Skip to main content
Premium Trial:

Request an Annual Quote

Thomas Widmann

Thomas Widmann has been appointed to the board of Cancer Genetics. He founded Actelion Pharmaceuticals and is a venture partner at Wellington Partners. Wildmann is also the founder of Hesperion, Widmann Associates, and Auraglobe. Before that he spent nine years at Hoffmann-La Roche where he led the international cardiovascular development department. 

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.